nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Betamethasone—multiple sclerosis	0.117	0.258	CrCtD
Fluoxymesterone—Dexamethasone—multiple sclerosis	0.117	0.258	CrCtD
Fluoxymesterone—Triamcinolone—multiple sclerosis	0.115	0.252	CrCtD
Fluoxymesterone—Prednisolone—multiple sclerosis	0.106	0.233	CrCtD
Fluoxymesterone—NR3C1—Methylprednisolone—multiple sclerosis	0.0442	0.248	CbGbCtD
Fluoxymesterone—NR3C1—Triamcinolone—multiple sclerosis	0.0335	0.188	CbGbCtD
Fluoxymesterone—NR3C1—Betamethasone—multiple sclerosis	0.0288	0.161	CbGbCtD
Fluoxymesterone—NR3C1—Prednisolone—multiple sclerosis	0.0284	0.159	CbGbCtD
Fluoxymesterone—NR3C1—Prednisone—multiple sclerosis	0.0268	0.15	CbGbCtD
Fluoxymesterone—NR3C1—Dexamethasone—multiple sclerosis	0.0167	0.0938	CbGbCtD
Fluoxymesterone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.00537	0.017	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00524	0.0166	CrCrCtD
Fluoxymesterone—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.00479	0.0152	CrCrCtD
Fluoxymesterone—Danazol—Prednisone—multiple sclerosis	0.00454	0.0144	CrCrCtD
Fluoxymesterone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00432	0.0137	CrCrCtD
Fluoxymesterone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00419	0.0133	CrCrCtD
Fluoxymesterone—Testolactone—Methylprednisolone—multiple sclerosis	0.00407	0.0129	CrCrCtD
Fluoxymesterone—Testolactone—Betamethasone—multiple sclerosis	0.004	0.0127	CrCrCtD
Fluoxymesterone—Testolactone—Dexamethasone—multiple sclerosis	0.004	0.0127	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisone—multiple sclerosis	0.00395	0.0125	CrCrCtD
Fluoxymesterone—Testolactone—Triamcinolone—multiple sclerosis	0.00391	0.0124	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisolone—multiple sclerosis	0.00385	0.0122	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisone—multiple sclerosis	0.00382	0.0121	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00373	0.0118	CrCrCtD
Fluoxymesterone—Testolactone—Prednisone—multiple sclerosis	0.00371	0.0117	CrCrCtD
Fluoxymesterone—Amcinonide—Dexamethasone—multiple sclerosis	0.00368	0.0116	CrCrCtD
Fluoxymesterone—Amcinonide—Betamethasone—multiple sclerosis	0.00368	0.0116	CrCrCtD
Fluoxymesterone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00364	0.0115	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00364	0.0115	CrCrCtD
Fluoxymesterone—Testolactone—Prednisolone—multiple sclerosis	0.00362	0.0115	CrCrCtD
Fluoxymesterone—Amcinonide—Triamcinolone—multiple sclerosis	0.00359	0.0114	CrCrCtD
Fluoxymesterone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00358	0.0113	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00358	0.0113	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00358	0.0113	CrCrCtD
Fluoxymesterone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00358	0.0113	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.0035	0.0111	CrCrCtD
Fluoxymesterone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.0035	0.0111	CrCrCtD
Fluoxymesterone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00346	0.011	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisone—multiple sclerosis	0.00341	0.0108	CrCrCtD
Fluoxymesterone—Desoximetasone—Dexamethasone—multiple sclerosis	0.00341	0.0108	CrCrCtD
Fluoxymesterone—Desoximetasone—Betamethasone—multiple sclerosis	0.00341	0.0108	CrCrCtD
Fluoxymesterone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CrCrCtD
Fluoxymesterone—Loteprednol—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CrCrCtD
Fluoxymesterone—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CrCrCtD
Fluoxymesterone—Mometasone—Methylprednisolone—multiple sclerosis	0.00338	0.0107	CrCrCtD
Fluoxymesterone—Desoximetasone—Triamcinolone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisolone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Mometasone—Betamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Triamcinolone—Dexamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Fluorometholone—Dexamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Fluorometholone—Betamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Loteprednol—Betamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Loteprednol—Dexamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Triamcinolone—Betamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Mometasone—Dexamethasone—multiple sclerosis	0.00333	0.0105	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisone—multiple sclerosis	0.00332	0.0105	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisone—multiple sclerosis	0.00332	0.0105	CrCrCtD
Fluoxymesterone—Betamethasone—Methylprednisolone—multiple sclerosis	0.0033	0.0105	CrCrCtD
Fluoxymesterone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.0033	0.0105	CrCrCtD
Fluoxymesterone—Dexamethasone—Betamethasone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Betamethasone—Dexamethasone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Loteprednol—Triamcinolone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Mometasone—Triamcinolone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Fluorometholone—Triamcinolone—multiple sclerosis	0.00325	0.0103	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisolone—multiple sclerosis	0.00324	0.0103	CrCrCtD
Fluoxymesterone—Progesterone—Prednisolone—multiple sclerosis	0.00324	0.0103	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00324	0.0103	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisone—multiple sclerosis	0.00324	0.0103	CrCrCtD
Fluoxymesterone—Dexamethasone—Triamcinolone—multiple sclerosis	0.00318	0.0101	CrCrCtD
Fluoxymesterone—Betamethasone—Triamcinolone—multiple sclerosis	0.00318	0.0101	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisolone—multiple sclerosis	0.00316	0.01	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisone—multiple sclerosis	0.00316	0.01	CrCrCtD
Fluoxymesterone—Peliosis hepatis—Azathioprine—multiple sclerosis	0.00312	0.145	CcSEcCtD
Fluoxymesterone—Prednisolone—Methylprednisolone—multiple sclerosis	0.00309	0.00979	CrCrCtD
Fluoxymesterone—Mometasone—Prednisone—multiple sclerosis	0.00309	0.00977	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00309	0.00977	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisone—multiple sclerosis	0.00309	0.00977	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisone—multiple sclerosis	0.00309	0.00977	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisone—multiple sclerosis	0.00309	0.00977	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisolone—multiple sclerosis	0.00309	0.00976	CrCrCtD
Fluoxymesterone—Prednisolone—Dexamethasone—multiple sclerosis	0.00304	0.00964	CrCrCtD
Fluoxymesterone—Prednisolone—Betamethasone—multiple sclerosis	0.00304	0.00964	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisone—multiple sclerosis	0.00302	0.00954	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisone—multiple sclerosis	0.00302	0.00954	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisolone—multiple sclerosis	0.00301	0.00953	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisolone—multiple sclerosis	0.00301	0.00953	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.00301	0.00953	CrCrCtD
Fluoxymesterone—Mometasone—Prednisolone—multiple sclerosis	0.00301	0.00953	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisolone—multiple sclerosis	0.00301	0.00953	CrCrCtD
Fluoxymesterone—Prednisolone—Triamcinolone—multiple sclerosis	0.00297	0.00941	CrCrCtD
Fluoxymesterone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00297	0.0094	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisolone—multiple sclerosis	0.00294	0.00931	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisolone—multiple sclerosis	0.00294	0.00931	CrCrCtD
Fluoxymesterone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00292	0.00925	CrCrCtD
Fluoxymesterone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00292	0.00925	CrCrCtD
Fluoxymesterone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00286	0.00904	CrCrCtD
Fluoxymesterone—Prednisolone—Prednisone—multiple sclerosis	0.00282	0.00893	CrCrCtD
Fluoxymesterone—Testosterone—Prednisolone—multiple sclerosis	0.00282	0.00891	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisone—multiple sclerosis	0.00271	0.00858	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisolone—multiple sclerosis	0.00265	0.00837	CrCrCtD
Fluoxymesterone—Polycythaemia—Prednisone—multiple sclerosis	0.000863	0.0402	CcSEcCtD
Fluoxymesterone—Oligospermia—Methotrexate—multiple sclerosis	0.000752	0.035	CcSEcCtD
Fluoxymesterone—Azoospermia—Methotrexate—multiple sclerosis	0.000585	0.0272	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Prednisolone—multiple sclerosis	0.000468	0.0218	CcSEcCtD
Fluoxymesterone—Hirsutism—Prednisolone—multiple sclerosis	0.000446	0.0208	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Azathioprine—multiple sclerosis	0.000445	0.0207	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Triamcinolone—multiple sclerosis	0.000431	0.0201	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Methylprednisolone—multiple sclerosis	0.00043	0.02	CcSEcCtD
Fluoxymesterone—Hirsutism—Triamcinolone—multiple sclerosis	0.00041	0.0191	CcSEcCtD
Fluoxymesterone—Hirsutism—Methylprednisolone—multiple sclerosis	0.000409	0.0191	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Betamethasone—multiple sclerosis	0.000391	0.0182	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Dexamethasone—multiple sclerosis	0.000391	0.0182	CcSEcCtD
Fluoxymesterone—Alopecia—Fingolimod—multiple sclerosis	0.000376	0.0175	CcSEcCtD
Fluoxymesterone—Hirsutism—Betamethasone—multiple sclerosis	0.000372	0.0173	CcSEcCtD
Fluoxymesterone—Hirsutism—Dexamethasone—multiple sclerosis	0.000372	0.0173	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.00036	0.0168	CcSEcCtD
Fluoxymesterone—Dydrogesterone—PGR—multiple sclerosis	0.000344	0.203	CrCbGaD
Fluoxymesterone—Menstruation irregular—Prednisone—multiple sclerosis	0.00034	0.0159	CcSEcCtD
Fluoxymesterone—Hirsutism—Prednisone—multiple sclerosis	0.000324	0.0151	CcSEcCtD
Fluoxymesterone—Paraesthesia—Fingolimod—multiple sclerosis	0.000272	0.0127	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.000271	0.0126	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Dexamethasone—multiple sclerosis	0.000246	0.0115	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Betamethasone—multiple sclerosis	0.000246	0.0115	CcSEcCtD
Fluoxymesterone—Haemoglobin—Cladribine—multiple sclerosis	0.000243	0.0113	CcSEcCtD
Fluoxymesterone—Haemorrhage—Cladribine—multiple sclerosis	0.000241	0.0112	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000237	0.011	CcSEcCtD
Fluoxymesterone—Danazol—CCL2—multiple sclerosis	0.00022	0.13	CrCbGaD
Fluoxymesterone—Amenorrhoea—Prednisone—multiple sclerosis	0.000214	0.00999	CcSEcCtD
Fluoxymesterone—Alopecia—Cladribine—multiple sclerosis	0.000213	0.00994	CcSEcCtD
Fluoxymesterone—Megestrol acetate—PGR—multiple sclerosis	0.000207	0.122	CrCbGaD
Fluoxymesterone—Haemoglobin—Azathioprine—multiple sclerosis	0.000197	0.00919	CcSEcCtD
Fluoxymesterone—Haemorrhage—Azathioprine—multiple sclerosis	0.000196	0.00915	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000194	0.00906	CcSEcCtD
Fluoxymesterone—Headache—Fingolimod—multiple sclerosis	0.00019	0.00883	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000179	0.00833	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000178	0.00831	CcSEcCtD
Fluoxymesterone—Anxiety—Cladribine—multiple sclerosis	0.000178	0.00831	CcSEcCtD
Fluoxymesterone—Alopecia—Azathioprine—multiple sclerosis	0.000174	0.00808	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000162	0.00756	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000162	0.00756	CcSEcCtD
Fluoxymesterone—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00016	0.00743	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000159	0.00739	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cladribine—multiple sclerosis	0.000154	0.00718	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Methotrexate—multiple sclerosis	0.000141	0.00656	CcSEcCtD
Fluoxymesterone—Alopecia—Mitoxantrone—multiple sclerosis	0.00014	0.00653	CcSEcCtD
Fluoxymesterone—Danazol—PGR—multiple sclerosis	0.000134	0.0793	CrCbGaD
Fluoxymesterone—Haemoglobin—Prednisolone—multiple sclerosis	0.000131	0.0061	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisolone—multiple sclerosis	0.00013	0.00607	CcSEcCtD
Fluoxymesterone—Spironolactone—PGR—multiple sclerosis	0.000129	0.076	CrCbGaD
Fluoxymesterone—Hypersensitivity—Cladribine—multiple sclerosis	0.000126	0.00589	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.00012	0.0712	CrCbGaD
Fluoxymesterone—Haemoglobin—Triamcinolone—multiple sclerosis	0.00012	0.00561	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00012	0.00559	CcSEcCtD
Fluoxymesterone—Haemorrhage—Triamcinolone—multiple sclerosis	0.00012	0.00558	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000119	0.00557	CcSEcCtD
Fluoxymesterone—Norethindrone—PGR—multiple sclerosis	0.000119	0.0706	CrCbGaD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000118	0.0055	CcSEcCtD
Fluoxymesterone—Anxiety—Mitoxantrone—multiple sclerosis	0.000117	0.00546	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000113	0.00525	CcSEcCtD
Fluoxymesterone—Betamethasone—PGR—multiple sclerosis	0.000109	0.0647	CrCbGaD
Fluoxymesterone—Haemoglobin—Betamethasone—multiple sclerosis	0.000109	0.00509	CcSEcCtD
Fluoxymesterone—Haemoglobin—Dexamethasone—multiple sclerosis	0.000109	0.00509	CcSEcCtD
Fluoxymesterone—Haemorrhage—Betamethasone—multiple sclerosis	0.000109	0.00506	CcSEcCtD
Fluoxymesterone—Haemorrhage—Dexamethasone—multiple sclerosis	0.000109	0.00506	CcSEcCtD
Fluoxymesterone—Headache—Cladribine—multiple sclerosis	0.000107	0.00501	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000103	0.00479	CcSEcCtD
Fluoxymesterone—Nausea—Cladribine—multiple sclerosis	0.000102	0.00475	CcSEcCtD
Fluoxymesterone—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000101	0.00472	CcSEcCtD
Fluoxymesterone—Alopecia—Betamethasone—multiple sclerosis	9.6e-05	0.00447	CcSEcCtD
Fluoxymesterone—Alopecia—Dexamethasone—multiple sclerosis	9.6e-05	0.00447	CcSEcCtD
Fluoxymesterone—Haemoglobin—Prednisone—multiple sclerosis	9.51e-05	0.00443	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisone—multiple sclerosis	9.46e-05	0.00441	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Prednisolone—multiple sclerosis	9.25e-05	0.00431	CcSEcCtD
Fluoxymesterone—Triamcinolone—BCHE—multiple sclerosis	9.15e-05	0.0541	CrCbGaD
Fluoxymesterone—Anxiety—Methylprednisolone—multiple sclerosis	8.83e-05	0.00411	CcSEcCtD
Fluoxymesterone—Headache—Azathioprine—multiple sclerosis	8.74e-05	0.00407	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.51e-05	0.00396	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.49e-05	0.00395	CcSEcCtD
Fluoxymesterone—Alopecia—Prednisone—multiple sclerosis	8.36e-05	0.00389	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.31e-05	0.00387	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisolone—multiple sclerosis	8.31e-05	0.00387	CcSEcCtD
Fluoxymesterone—Nausea—Azathioprine—multiple sclerosis	8.29e-05	0.00386	CcSEcCtD
Fluoxymesterone—Anxiety—Dexamethasone—multiple sclerosis	8.03e-05	0.00374	CcSEcCtD
Fluoxymesterone—Anxiety—Betamethasone—multiple sclerosis	8.03e-05	0.00374	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methotrexate—multiple sclerosis	7.95e-05	0.0037	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methotrexate—multiple sclerosis	7.91e-05	0.00368	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.8e-05	0.0029	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GPC5—multiple sclerosis	7.79e-05	0.00289	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Betamethasone—multiple sclerosis	7.72e-05	0.0036	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.72e-05	0.0036	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	7.68e-05	0.00285	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Triamcinolone—multiple sclerosis	7.64e-05	0.00356	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methylprednisolone—multiple sclerosis	7.62e-05	0.00355	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—MALT1—multiple sclerosis	7.57e-05	0.00281	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	7.55e-05	0.0028	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRF5—multiple sclerosis	7.45e-05	0.00277	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	7.41e-05	0.00275	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	7.31e-05	0.00271	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—multiple sclerosis	7.29e-05	0.00271	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	7.28e-05	0.0027	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	7.2e-05	0.00267	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	7.12e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRF8—multiple sclerosis	7.12e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFIH1—multiple sclerosis	7.12e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-G—multiple sclerosis	7.12e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	7.11e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—Headache—Mitoxantrone—multiple sclerosis	7.06e-05	0.00329	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	7e-05	0.0026	CbGpPWpGaD
Fluoxymesterone—Anxiety—Prednisone—multiple sclerosis	6.99e-05	0.00326	CcSEcCtD
Fluoxymesterone—Alopecia—Methotrexate—multiple sclerosis	6.99e-05	0.00326	CcSEcCtD
Fluoxymesterone—Progesterone—PGR—multiple sclerosis	6.96e-05	0.0411	CrCbGaD
Fluoxymesterone—Paraesthesia—Betamethasone—multiple sclerosis	6.93e-05	0.00323	CcSEcCtD
Fluoxymesterone—Paraesthesia—Dexamethasone—multiple sclerosis	6.93e-05	0.00323	CcSEcCtD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	6.92e-05	0.00257	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisolone—multiple sclerosis	6.82e-05	0.00317	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—RGS1—multiple sclerosis	6.81e-05	0.00253	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	6.73e-05	0.0025	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	6.72e-05	0.0025	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Prednisone—multiple sclerosis	6.72e-05	0.00313	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL2—multiple sclerosis	6.71e-05	0.00249	CbGpPWpGaD
Fluoxymesterone—Nausea—Mitoxantrone—multiple sclerosis	6.7e-05	0.00312	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	6.69e-05	0.00248	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TNFAIP3—multiple sclerosis	6.66e-05	0.00247	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	6.58e-05	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	6.5e-05	0.00242	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GPR65—multiple sclerosis	6.46e-05	0.0024	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	6.44e-05	0.00239	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—multiple sclerosis	6.43e-05	0.00239	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	6.4e-05	0.00238	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PGR—multiple sclerosis	6.36e-05	0.0376	CrCbGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	6.34e-05	0.00236	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Triamcinolone—multiple sclerosis	6.27e-05	0.00292	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.25e-05	0.00291	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	6.17e-05	0.00229	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Prednisone—multiple sclerosis	6.04e-05	0.00281	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CD28—multiple sclerosis	5.99e-05	0.00223	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR1—multiple sclerosis	5.91e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL13—multiple sclerosis	5.91e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTPRC—multiple sclerosis	5.89e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CCR2—multiple sclerosis	5.89e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—Headache—Prednisolone—multiple sclerosis	5.8e-05	0.0027	CcSEcCtD
Fluoxymesterone—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	5.78e-05	0.00215	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	5.74e-05	0.00213	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DPB1—multiple sclerosis	5.69e-05	0.00211	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	5.65e-05	0.0021	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Methotrexate—multiple sclerosis	5.62e-05	0.00262	CcSEcCtD
Fluoxymesterone—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	5.62e-05	0.00209	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	5.58e-05	0.00207	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.55e-05	0.00206	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	5.54e-05	0.00206	CbGpPWpGaD
Fluoxymesterone—Nausea—Prednisolone—multiple sclerosis	5.5e-05	0.00256	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—ITGA4—multiple sclerosis	5.47e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD40—multiple sclerosis	5.47e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNB1—multiple sclerosis	5.43e-05	0.00202	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTLA4—multiple sclerosis	5.39e-05	0.002	CbGpPWpGaD
Fluoxymesterone—Headache—Triamcinolone—multiple sclerosis	5.33e-05	0.00248	CcSEcCtD
Fluoxymesterone—Headache—Methylprednisolone—multiple sclerosis	5.32e-05	0.00248	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	5.23e-05	0.00194	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	5.13e-05	0.00191	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	5.05e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—Nausea—Triamcinolone—multiple sclerosis	5.05e-05	0.00235	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methotrexate—multiple sclerosis	5.05e-05	0.00235	CcSEcCtD
Fluoxymesterone—Nausea—Methylprednisolone—multiple sclerosis	5.04e-05	0.00235	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	5e-05	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	4.98e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ZNF746—multiple sclerosis	4.96e-05	0.00184	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisone—multiple sclerosis	4.95e-05	0.00231	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	4.93e-05	0.00183	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	4.9e-05	0.00182	CbGpPWpGaD
Fluoxymesterone—Headache—Dexamethasone—multiple sclerosis	4.84e-05	0.00225	CcSEcCtD
Fluoxymesterone—Headache—Betamethasone—multiple sclerosis	4.84e-05	0.00225	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—VCAM1—multiple sclerosis	4.76e-05	0.00177	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DQA1—multiple sclerosis	4.75e-05	0.00176	CbGpPWpGaD
Fluoxymesterone—Nausea—Dexamethasone—multiple sclerosis	4.59e-05	0.00214	CcSEcCtD
Fluoxymesterone—Nausea—Betamethasone—multiple sclerosis	4.59e-05	0.00214	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—PTBP1—multiple sclerosis	4.53e-05	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	4.49e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	4.48e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.45e-05	0.00165	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DQB1—multiple sclerosis	4.44e-05	0.00165	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—multiple sclerosis	4.41e-05	0.00164	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	4.4e-05	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	4.3e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD86—multiple sclerosis	4.28e-05	0.00159	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.27e-05	0.00159	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	4.23e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	4.22e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—Headache—Prednisone—multiple sclerosis	4.21e-05	0.00196	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CCL3—multiple sclerosis	4.21e-05	0.00156	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD40LG—multiple sclerosis	4.19e-05	0.00156	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.18e-05	0.00155	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD8A—multiple sclerosis	4.15e-05	0.00154	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—multiple sclerosis	4.14e-05	0.00193	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.09e-05	0.00152	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTGER4—multiple sclerosis	4.05e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	4.01e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—Nausea—Prednisone—multiple sclerosis	3.99e-05	0.00186	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—HLA-B—multiple sclerosis	3.99e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PGR—multiple sclerosis	3.99e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—PRLR—brain—multiple sclerosis	3.99e-05	0.161	CbGeAlD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.97e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—multiple sclerosis	3.94e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—FAS—multiple sclerosis	3.93e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCR3—multiple sclerosis	3.91e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	3.91e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.89e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CD28—multiple sclerosis	3.88e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	3.82e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZNF746—multiple sclerosis	3.82e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.81e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR2—multiple sclerosis	3.81e-05	0.00141	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.79e-05	0.00141	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	3.76e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	3.76e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2RA—multiple sclerosis	3.74e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	3.73e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-A—multiple sclerosis	3.7e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	3.63e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	3.61e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	3.56e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—Headache—Methotrexate—multiple sclerosis	3.52e-05	0.00164	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CNR1—multiple sclerosis	3.51e-05	0.0013	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PTBP1—multiple sclerosis	3.49e-05	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	3.48e-05	0.00129	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.45e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	3.44e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	3.44e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—U2AF2—multiple sclerosis	3.44e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HNRNPA1—multiple sclerosis	3.44e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.43e-05	0.00127	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TLR4—multiple sclerosis	3.38e-05	0.00126	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DRB1—multiple sclerosis	3.38e-05	0.00125	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ALB—multiple sclerosis	3.36e-05	0.0198	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	3.35e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—Nausea—Methotrexate—multiple sclerosis	3.34e-05	0.00155	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	3.31e-05	0.00123	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ICAM1—multiple sclerosis	3.24e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	3.21e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—ALB—multiple sclerosis	3.19e-05	0.0188	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL10—multiple sclerosis	3.16e-05	0.00117	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD80—multiple sclerosis	3.12e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	3.11e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	3.06e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	3.05e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	3.04e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	3e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	2.99e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	2.99e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.98e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	2.94e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.94e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.93e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	2.92e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CD86—multiple sclerosis	2.76e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	2.76e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL5—multiple sclerosis	2.72e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ZFP36L1—multiple sclerosis	2.72e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.66e-05	0.000987	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—U2AF2—multiple sclerosis	2.65e-05	0.000983	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	2.65e-05	0.000983	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TYK2—multiple sclerosis	2.63e-05	0.000978	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.62e-05	0.000973	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.62e-05	0.000972	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	2.61e-05	0.000968	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	2.61e-05	0.000968	CbGpPWpGaD
Fluoxymesterone—NR3C1—nerve—multiple sclerosis	2.6e-05	0.105	CbGeAlD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	2.57e-05	0.000956	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	2.54e-05	0.000941	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SPP1—multiple sclerosis	2.52e-05	0.000936	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	2.47e-05	0.000917	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNG—multiple sclerosis	2.47e-05	0.000916	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR5—multiple sclerosis	2.45e-05	0.000911	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2RA—multiple sclerosis	2.42e-05	0.000898	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	2.39e-05	0.000889	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD4—multiple sclerosis	2.38e-05	0.000885	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	2.36e-05	0.000875	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	2.24e-05	0.000834	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—multiple sclerosis	2.23e-05	0.000829	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.21e-05	0.000821	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—multiple sclerosis	2.2e-05	0.000817	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—multiple sclerosis	2.19e-05	0.000814	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	2.17e-05	0.000806	CbGpPWpGaD
Fluoxymesterone—SHBG—brainstem—multiple sclerosis	2.15e-05	0.0868	CbGeAlD
Fluoxymesterone—AR—Gene Expression—PABPC1—multiple sclerosis	2.11e-05	0.000782	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.1e-05	0.000778	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	2.09e-05	0.000777	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	2.06e-05	0.000765	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.05e-05	0.000761	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CD80—multiple sclerosis	2.02e-05	0.000749	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.99e-05	0.000739	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	1.98e-05	0.000737	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.95e-05	0.000723	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.93e-05	0.000716	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—multiple sclerosis	1.92e-05	0.000712	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.9e-05	0.000706	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL5—multiple sclerosis	1.9e-05	0.000705	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—multiple sclerosis	1.88e-05	0.000696	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—multiple sclerosis	1.85e-05	0.0109	CrCbGaD
Fluoxymesterone—PRLR—Immune System—STAT3—multiple sclerosis	1.84e-05	0.000685	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	1.79e-05	0.000664	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.74e-05	0.000645	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.73e-05	0.000643	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	1.72e-05	0.000639	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TYK2—multiple sclerosis	1.7e-05	0.000632	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.7e-05	0.000631	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK1—multiple sclerosis	1.68e-05	0.000623	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	1.67e-05	0.000621	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—multiple sclerosis	1.67e-05	0.00062	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	1.65e-05	0.000612	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PABPC1—multiple sclerosis	1.62e-05	0.000602	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.62e-05	0.000601	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.61e-05	0.0006	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	1.6e-05	0.000593	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.58e-05	0.000587	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	1.57e-05	0.000583	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.53e-05	0.00057	CbGpPWpGaD
Fluoxymesterone—ESR1—brainstem—multiple sclerosis	1.51e-05	0.0611	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	1.5e-05	0.000559	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—multiple sclerosis	1.5e-05	0.000555	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL5—multiple sclerosis	1.46e-05	0.000543	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GPC5—multiple sclerosis	1.46e-05	0.000543	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.44e-05	0.000536	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.44e-05	0.000535	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—multiple sclerosis	1.42e-05	0.000526	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.35e-05	0.0005	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—multiple sclerosis	1.34e-05	0.000498	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.34e-05	0.000497	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.33e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.31e-05	0.000486	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—multiple sclerosis	1.29e-05	0.000478	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RGS1—multiple sclerosis	1.28e-05	0.000475	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.25e-05	0.000463	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GPR65—multiple sclerosis	1.21e-05	0.00045	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	1.21e-05	0.000448	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—multiple sclerosis	1.19e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.16e-05	0.000432	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—multiple sclerosis	1.15e-05	0.000428	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—multiple sclerosis	1.13e-05	0.000421	CbGpPWpGaD
Fluoxymesterone—NR3C1—brainstem—multiple sclerosis	1.12e-05	0.0451	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	1.11e-05	0.000412	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR1—multiple sclerosis	1.11e-05	0.000412	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—multiple sclerosis	1.11e-05	0.000411	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—multiple sclerosis	1.11e-05	0.00041	CbGpPWpGaD
Fluoxymesterone—SHBG—central nervous system—multiple sclerosis	1.08e-05	0.0438	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	0.000403	CbGpPWpGaD
Fluoxymesterone—SHBG—cerebellum—multiple sclerosis	1.06e-05	0.0428	CbGeAlD
Fluoxymesterone—AR—Gene Expression—VDR—multiple sclerosis	1.04e-05	0.000388	CbGpPWpGaD
Fluoxymesterone—AR—spinal cord—multiple sclerosis	9.59e-06	0.0387	CbGeAlD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	8.63e-06	0.00032	CbGpPWpGaD
Fluoxymesterone—SHBG—brain—multiple sclerosis	8.61e-06	0.0347	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—multiple sclerosis	8.33e-06	0.000309	CbGpPWpGaD
Fluoxymesterone—AR—nervous system—multiple sclerosis	8.08e-06	0.0326	CbGeAlD
Fluoxymesterone—ESR1—Gene Expression—VDR—multiple sclerosis	8.05e-06	0.000299	CbGpPWpGaD
Fluoxymesterone—ESR1—nervous system—multiple sclerosis	7.94e-06	0.032	CbGeAlD
Fluoxymesterone—NR3C1—Gene Expression—VDR—multiple sclerosis	7.93e-06	0.000294	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL3—multiple sclerosis	7.9e-06	0.000293	CbGpPWpGaD
Fluoxymesterone—NR3C1—medulla oblongata—multiple sclerosis	7.79e-06	0.0314	CbGeAlD
Fluoxymesterone—AR—central nervous system—multiple sclerosis	7.78e-06	0.0314	CbGeAlD
Fluoxymesterone—ESR1—central nervous system—multiple sclerosis	7.64e-06	0.0308	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	7.61e-06	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—multiple sclerosis	7.49e-06	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—cerebellum—multiple sclerosis	7.47e-06	0.0301	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	7.35e-06	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD28—multiple sclerosis	7.28e-06	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR2—multiple sclerosis	7.15e-06	0.000265	CbGpPWpGaD
Fluoxymesterone—NR3C1—midbrain—multiple sclerosis	7.12e-06	0.0287	CbGeAlD
Fluoxymesterone—NR3C1—spinal cord—multiple sclerosis	6.95e-06	0.028	CbGeAlD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	6.65e-06	0.000247	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR1—multiple sclerosis	6.59e-06	0.000245	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	6.54e-06	0.000243	CbGpPWpGaD
Fluoxymesterone—AR—brain—multiple sclerosis	6.18e-06	0.0249	CbGeAlD
Fluoxymesterone—ESR1—brain—multiple sclerosis	6.07e-06	0.0245	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	5.94e-06	0.00022	CbGpPWpGaD
Fluoxymesterone—NR3C1—nervous system—multiple sclerosis	5.86e-06	0.0236	CbGeAlD
Fluoxymesterone—NR3C1—central nervous system—multiple sclerosis	5.64e-06	0.0227	CbGeAlD
Fluoxymesterone—NR3C1—cerebellum—multiple sclerosis	5.51e-06	0.0222	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—CD86—multiple sclerosis	5.19e-06	0.000193	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL5—multiple sclerosis	5.11e-06	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPP1—multiple sclerosis	4.73e-06	0.000176	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR5—multiple sclerosis	4.6e-06	0.000171	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	4.54e-06	0.000169	CbGpPWpGaD
Fluoxymesterone—NR3C1—brain—multiple sclerosis	4.48e-06	0.0181	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—multiple sclerosis	4.19e-06	0.000156	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—multiple sclerosis	4.15e-06	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD80—multiple sclerosis	3.79e-06	0.000141	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—multiple sclerosis	3.6e-06	0.000134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—multiple sclerosis	3.52e-06	0.000131	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—multiple sclerosis	3.2e-06	0.000119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TYK2—multiple sclerosis	3.2e-06	0.000119	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—multiple sclerosis	3.15e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—multiple sclerosis	2.66e-06	9.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—multiple sclerosis	2.52e-06	9.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—multiple sclerosis	2.24e-06	8.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—multiple sclerosis	2.08e-06	7.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	2.08e-06	7.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	2.03e-06	7.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—multiple sclerosis	1.56e-06	5.81e-05	CbGpPWpGaD
